SCHEMBL8767709

SCHEMBL8767709

CC/C(=C(\c1ccc(I)cc1)c1ccc(OCCCN(C)C)cc1)c1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE1A P54750 11/20 1.00
PDE1B Q01064 11/20 1.00
PDE1C Q14123 11/20 1.00
ESR1 P03372 7/20 0.77
ESR2 Q92731 5/20 0.77
MAPT P10636 3/20 0.77
MEN1 O00255 2/20 0.77
TP53 P04637 2/20 0.77
PGR P06401 2/20 0.77
CYP3A4 P08684 2/20 0.77
ESRRG P62508 2/20 0.77
KMT2A Q03164 2/20 0.77
NPC1 O15118 1/20 0.77
NR1I2 O75469 1/20 0.77
PRKD3 O94806 1/20 0.77
ABCB11 O95342 1/20 0.77
EGFR P00533 1/20 0.77
GBA1 P04062 1/20 0.77
NR3C1 P04150 1/20 0.77
ERBB2 P04626 1/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8767718 1.00 PDE1A (1.00) PDE1APDE1BPDE1CESR1ESR2
SCHEMBL8767725 1.00 PDE1A (1.00) PDE1APDE1BPDE1CESR1ESR2
SCHEMBL8767675 0.96 PDE1A (1.00) PDE1APDE1BPDE1CESR1ESR2
SCHEMBL8767686 0.96 PDE1A (1.00) PDE1APDE1BPDE1CESR1ESR2
SCHEMBL8767678 0.96 PDE1A (1.00) PDE1APDE1BPDE1CESR1ESR2
SCHEMBL1151532 0.94 PDE1A (1.00) PDE1APDE1BPDE1CESR1ESR2
SCHEMBL2827282 0.94 PDE1A (1.00) PDE1APDE1BPDE1CESR1ESR2
SCHEMBL7797462 0.94 PDE1A (1.00) PDE1APDE1BPDE1CESR1ESR2
SCHEMBL7797461 0.94 PDE1A (1.00) PDE1APDE1BPDE1CESR1ESR2
SCHEMBL23266944 0.94 PDE1A (0.88) PDE1APDE1BPDE1CESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0638064-B1 SUBSTITUTED 1,1,2-TRIPHENYLBUTENES AND THEIR USE IN THE TREATMENT AND DIAGNOSIS OF CANCER BRITISH TECH GROUP (GB) 1997-08-13 EP disclosed
EP-0638064-A1 SUBSTITUTED 1,1,2-TRIPHENYLBUTENES AND THEIR USE IN THE TREATMENT AND DIAGNOSIS OF CANCER. BRITISH TECH GROUP (GB) 1995-02-15 EP disclosed
WO-1993022275-A1 SUBSTITUTED 1,1,2-TRIPHENYLBUTENES AND THEIR USE IN THE TREATMENT AND DIAGNOSIS OF CANCER BRITISH TECHNOLOGY GROUP LTD (GB) 1993-11-11 WO disclosed